Scarica l'app Stockscreener
307.88
1.41%
3.82
Dopo l'orario di chiusura:
307.78
-0.10
-0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$304.06
Aprire:
$303.41
Volume 24 ore:
122.38K
Relative Volume:
0.55
Capitalizzazione di mercato:
$6.55B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-11.27
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
-1.59%
1M Prestazione:
-0.54%
6M Prestazione:
+24.00%
1 anno Prestazione:
-1.53%
Intervallo 1D:
$296.15
$311.47
Intervallo di 1 settimana:
$296.15
$328.52
Portata 52W:
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
307.88 | 8.20B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
130.01 | 226.11B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
359.60 | 137.72B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.82 | 123.49B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
BSX
Boston Scientific Corp
|
99.24 | 150.85B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
GEHC
Ge Healthcare Technologies Inc
|
71.02 | 32.17B | 20.25B | 2.29B | 1.40B | 4.8366 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Is Bio Rad Laboratories Inc. (BUW) stock cheap vs fundamentalsStop Loss & High Accuracy Trade Signal Alerts - newser.com
Can Bio Rad Laboratories Inc. (BUWA) stock ride next bull market cycleJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com
Is Bio Rad Laboratories Inc. Class B stock expanding market penetrationWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
Is Bio Rad Laboratories Inc. Class B stock supported by free cash flowWeekly Loss Report & Verified Momentum Watchlists - newser.com
Is Bio Rad Laboratories Inc. Class stock at risk of policy regulation2025 Market Outlook & Growth Focused Investment Plans - newser.com
How Bio Rad Laboratories Inc. (BUWA) stock stacks up against competitors - newser.com
Why Bio Rad Laboratories Inc. (BUWA) stock is a must watch tickerPortfolio Return Summary & Real-Time Buy Signal Alerts - newser.com
Why analysts maintain buy rating on Bio Rad Laboratories Inc. (BUW) stock2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock deliver compounding returnsPortfolio Risk Report & Intraday High Probability Alerts - newser.com
Why Bio Rad Laboratories Inc. Class stock stays on top picks2025 Growth vs Value & Smart Allocation Stock Reports - newser.com
How Bio Rad Laboratories Inc. Class stock reacts to new regulationsJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
What to expect from Bio Rad Laboratories Inc. in the next 30 days - newser.com
What is the fair value estimate for Bio Rad Laboratories Inc. Class B stock in 2025Analyst Downgrade & Safe Capital Preservation Plans - newser.com
How geopolitical risks impact Bio Rad Laboratories Inc. (BUWA) stock2025 Market Outlook & Safe Capital Growth Tips - newser.com
What MACD trends signal for Bio Rad Laboratories Inc. (BUWA) stock2025 Technical Patterns & Weekly Momentum Picks - newser.com
Bio-Rad Laboratories (BIO) Price Target Increased by 14.15% to 362.10 - Nasdaq
Is Bio Rad Laboratories Inc. (BUW) stock a good hedge against inflation2025 Volume Leaders & Daily Price Action Insights - newser.com
Can trapped investors hope for a rebound in Bio Rad Laboratories Inc.Weekly Stock Analysis & Low Risk Growth Stock Ideas - newser.com
What RSI levels show for Bio Rad Laboratories Inc. Class stockEarnings Growth Summary & Weekly Hot Stock Watchlists - newser.com
Will Bio Rad Laboratories Inc. stock recover after recent dropJuly 2025 Summary & Verified Technical Signals - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock see valuation expansionJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com
Why Bio Rad Laboratories Inc. (BUW) stock is upgraded to buy2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
Bio Rad Laboratories Inc. stock trend forecastBear Alert & Weekly High Potential Stock Alerts - newser.com
Published on: 2025-11-16 16:33:28 - newser.com
How Bio Rad Laboratories Inc. (BUWA) stock performs in volatility spikesTrade Entry Summary & Reliable Trade Execution Plans - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock beat Nasdaq index returns - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock a buy during volatile marketsJuly 2025 Movers & High Yield Equity Trading Tips - newser.com
Will Bio Rad Laboratories Inc. Class B stock profit from fiscal stimulusTrend Reversal & Smart Allocation Stock Tips - newser.com
What earnings margins imply for Bio Rad Laboratories Inc. Class B stock2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Is Bio Rad Laboratories Inc. stock supported by strong cash flowsJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Is Bio Rad Laboratories Inc. meeting your algorithmic filter criteriaRate Cut & Low Risk Investment Opportunities - newser.com
Exit strategy if you’re trapped in Bio Rad Laboratories Inc.July 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com
Can Bio Rad Laboratories Inc. stock sustain revenue growthLong Setup & AI Forecasted Entry/Exit Points - newser.com
Why millennials buy Bio Rad Laboratories Inc. (BUWA) stock2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Will Bio Rad Laboratories Inc. Class B stock deliver stable dividendsWeekly Stock Report & High Accuracy Trade Alerts - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock attract long term capital inflowsPortfolio Gains Report & Verified Short-Term Plans - newser.com
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bio Rad Laboratories Inc Azioni (BIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BARRY JAMES | EVP, President, LSG |
Nov 06 '25 |
Sale |
306.18 |
700 |
214,289 |
510 |
0.18%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):